End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,810 KRW | -1.90% |
|
-5.53% | -51.86% |
06-10 | Shaperon and Dong-A St Sign MOU for Nanobody-Based New Drug Development | CI |
03-18 | Shaperon Enrolls its First Patient in Phase 2 U.S. Clinical Trial for Atopic Dermatitis Therapy 'Nugel' | CI |
- Stock Market
- Equities
- A378800 Stock
- News Shaperon Inc.